Vimarsana
Biggest News Aggregation in the World

Page 10 - Point Partners News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Point Partners. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Point Partners Today - Breaking & Trending Today

Needham & Company LLC Reaffirms "Buy" Rating for Immunocore (NASDAQ:IMCR) - Vimarsana News

Needham & Company LLC Reaffirms "Buy" Rating for Immunocore (NASDAQ:IMCR)

Needham & Company LLC restated their buy rating on shares of Immunocore (NASDAQ:IMCR – Free Report) in a report issued on Friday, Benzinga reports. Needham & Company LLC currently has a $81.00 price target on the stock. IMCR has been the topic of several other research reports. SVB Leerink assumed coverage on shares of Immunocore […]

EV, Charging & Battery News: Hyundai, VW, Shyft Group, Group 14, Ev Connect, bp pulse, ChargePoint, Redwood Materials & Mitsubishi - Vimarsana News

EV, Charging & Battery News: Hyundai, VW, Shyft Group, Group 14, Ev Connect, bp pulse, ChargePoint, Redwood Materials & Mitsubishi

In electric vehicle, charging and battery news are Hyundai, VW, Shyft Group, Group 14, Ev Connect, bp pulse, ChargePoint, Redwood Materials and Mitsubishi. VW Axes ID.7 Sedan in US for Now Volkswagen is committed to making market-driven choices while listening to our customers. As market dynamics continue to change, Volkswagen is delaying the introduction of

Terns Pharmaceuticals (NASDAQ:TERN) Earns "Neutral" Rating from HC Wainwright - Vimarsana News

Terns Pharmaceuticals (NASDAQ:TERN) Earns "Neutral" Rating from HC Wainwright

HC Wainwright reissued their neutral rating on shares of Terns Pharmaceuticals (NASDAQ:TERN – Free Report) in a research note issued to investors on Tuesday, Benzinga reports. The brokerage currently has a $5.50 price target on the stock. A number of other research analysts have also commented on TERN. JMP Securities decreased their price target on […]

Terns Pharmaceuticals (NASDAQ:TERN) Given "Neutral" Rating at HC Wainwright - Vimarsana News

Terns Pharmaceuticals (NASDAQ:TERN) Given "Neutral" Rating at HC Wainwright

HC Wainwright reaffirmed their neutral rating on shares of Terns Pharmaceuticals (NASDAQ:TERN – Free Report) in a report issued on Tuesday, Benzinga reports. They currently have a $5.50 target price on the stock. Several other research firms have also issued reports on TERN. JMP Securities lowered their price target on Terns Pharmaceuticals from $17.00 to […]

Terns Pharmaceuticals (NASDAQ:TERN) Earns Market Outperform Rating from JMP Securities - Vimarsana News

Terns Pharmaceuticals (NASDAQ:TERN) Earns Market Outperform Rating from JMP Securities

JMP Securities reiterated their market outperform rating on shares of Terns Pharmaceuticals (NASDAQ:TERN – Free Report) in a research note released on Tuesday morning, Benzinga reports. JMP Securities currently has a $15.00 target price on the stock. Other analysts also recently issued research reports about the stock. BMO Capital Markets increased their target price on […]